Positive Results in Late-Stage Trial for Lung Cancer Treatment
Eli Lilly & Co. (LLY) has reported significant progress in a Phase 3 clinical trial of their treatment for a specific type of non-small cell lung cancer. The trial, called…
Eli Lilly & Co. (LLY) has reported significant progress in a Phase 3 clinical trial of their treatment for a specific type of non-small cell lung cancer. The trial, called…
The FTSE 100 Index closed up 0.47% at 7,564.37, showcasing a positive day for U.K. stocks. Top Performers Rolls-Royce Holdings PLC (RR) led the gains with a significant increase of…
Friday's employment data suggests that there is a growing demand for new housing, particularly as potential sellers with low mortgage rates choose to stay put. According to the Bureau of…
Shares in Nabaltec, the German chemicals company, experienced a significant drop on Friday as the company adjusted its year-end forecast downwards. The primary reasons cited for this adjustment were weak…
Canada's official international reserves saw a positive growth in July, with a $228 million increase driven by investment gains, according to the federal finance department. As of July 31, the…
The recent downgrade of U.S. government debt by Fitch Ratings has caused quite a stir, but is it really that significant? While the credit worthiness of the U.S. government is…
On Wednesday, the stock market experienced a decline following Fitch Ratings' decision to lower its U.S. debt ratings from AAA to AA+. This downgrade was due to the country's increasing…
Louisville, KY - Humana Inc. (HUM, +0.28%) experienced a 2.6% increase in premarket trading on Wednesday, following the release of its second-quarter earnings report. The health insurance company surpassed earnings…
Amazon.com Inc. has announced that its virtual health care platform, Amazon Clinic, is now accessible to customers in all 50 states and Washington, D.C. This expansion comes after Amazon Clinic's…
Berlin, Germany— BMW shares experienced a decline on Tuesday following the release of the car maker's second-quarter financial report. Although the company raised its guidance for the auto segment for…
Navidea Biopharmaceuticals (NASDAQ: NAVB) has experienced a significant drop in its shares, with prices falling by 16% to 8 cents. The company has been grappling with the possibility of delisting…
Stock futures are slipping on Monday as the S&P 500 wraps up a successful month of gains. The focus this week on Wall Street will be on the earnings reports…